Hydrogen Patches Help Spinal Cord Injury Recovery in Rats
- Authors
- Haibo Wang, Yang Sun, Shiqi Wang, Wenbo Wang, Jincheng Tang, Ziang Li, Xinzhao Jiang, Liang Zhou, Jie Wu, Qiangqiang Guo, Yiwei Zhu, Yu Feng, Kun Xi, Liang Chen
- Journal
- Small
- Year
- 2026
- DOI
- 10.1002/smll.202514854
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Spinal Cord Injury
- Body System
- Nervous System
TL;DR
A dual hydrogen- and magnesium-releasing microneedle system reduced oxidative stress, modulated microglia, and improved functional recovery after spinal cord injury in rats.
Key Finding
A dual-release microneedle patch delivering hydrogen gas followed by magnesium reduced harmful reactive oxygen species by 55% and improved locomotor recovery in rats with spinal cord injury, with movement scores improving from 5.5 to 14.8 over 8 weeks.
Summary
Researchers developed a special patch containing magnesium microparticles that can penetrate the protective membrane surrounding the spinal cord. When implanted after spinal cord injury in rats, the patch releases hydrogen gas first (which reduces harmful molecules called reactive oxygen species by 55%), followed by magnesium (which helps immune cells switch to a repair mode and promotes nerve fiber growth). This two-stage approach improved movement recovery in injured rats compared to untreated controls.
Practical Takeaway
This is early-stage research conducted only in rats, so it cannot yet be applied to humans. While the results suggest hydrogen gas may help reduce oxidative stress after spinal cord injury when combined with magnesium, the patch requires surgical implantation and much more research—including human trials—would be needed before any clinical use. The findings are interesting for understanding how hydrogen might work in nerve injury, but they do not support any current consumer applications.
Abstract
Spinal cord injury (SCI) treatment is hindered by a "triple barrier:" the physical dura, a chemical storm of reactive oxygen species (ROS), and an immune barrier mediated by pro-inflammatory microglia. To address these, we developed a "Hydrogen/Magnesium dual-engine microneedle" (MN-Mg) system by embedding magnesium (Mg) microparticles within a methacrylated hyaluronic acid (HAMA) hydrogel matrix via micromolding. Possessing high mechanical strength, Mg-MNs penetrate the dura mater. Upon implantation, the system triggers a controllable magnesium-water reaction, initiating a spatiotemporally synergistic dual-engine therapeutic mode. The "hydrogen engine" rapidly releases high-concentration hydrogen gas (H2) during the acute SCI phase. It efficiently scavenges ROS storm (reducing levels by 55%) by inhibiting the MAPK pathway and downregulating AP-1 transcription, creating an antioxidant window for neural repair. Subsequently, the "magnesium engine" provides sustained Mg2 + release during the subacute phase, exerting a dual restorative effect: induces microglia polarization toward the pro-reparative M2 phenotype (4.8-fold increase) and promotes axonal regeneration (2.9-fold increase). This synergy leads to locomotor recovery in a rat SCI model, with scores improving from 5.5 ± 1.05 (Controls) to 14.8 ± 1.17 at 8 weeks. This "Penetration-Confinement-Dual-Engine Modulation" paradigm enables spatiotemporal synergistic H2/Mg therapy supported by an elucidated ROS-MAPK/AP-1 regulatory axis, advancing SCI treatment from symptomatic relief to targeted neural microenvironment reconstruction.